Global Competent Cells Market Size, Status and Forecast 2019-2025

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Asia-Pacific has the largest global export quantity and manufacturers in Competent Cells market, while the North America is the second sales volume market for Competent Cells in 2016.
In the industry, Merck KGaA profits most in 2016 and recent years, while Thermo Fisher Scientific and Agilent Technologies ranked 2 and 3.The market share of them is 13.28%, 9.52% and 7.00% in 2016.The gap of market share is keep on enlarged due to different strategy.
Nowadays, there are two mainly types of Competent Cells, including Chemically Competent Cells and Electrocompetent Cells. And Chemically Competent Cells is the main type for Competent Cells, and the Chemically Competent Cells reached a sales volume of approximately 42236 K Unit in 2016, with 64.12% of global sales volume.
Competent Cells technology is much mature now, and new enterprises can not surpass existing famous brands on reputation or design in the short term. So, the study group recommends the new entrants need to be considered carefully before enter into this field.
In 2018, the global Competent Cells market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Competent Cells status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Competent Cells development in United States, Europe and China.

The key players covered in this study
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems

Market segment by Type, the product can be split into
Chemically Competent Cells
Electrocompetent Cells

Market segment by Application, split into
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Competent Cells status, future forecast, growth opportunity, key market and key players.
To present the Competent Cells development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Competent Cells are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions